A Pan-Histone Deacetylase Inhibitor Enhances the Antitumor Activity of B7-H3–Specific CAR T Cells in Solid Tumors
Abstract
The limited efficacy of chimeric antigen receptor (CAR) T-cell therapies with solid malignancies prompted us to test whether epigenetic therapy could enhance the antitumor activity of B7-H3.CAR T cells with several solid cancer types.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 02, 2021
- Source ID
- 10.1158/1078-0432.ccr-20-2487
Entities
People
- Bakhos A Tannous
- Bowen Li
- Fan Wu
- Filippos Kontos
- Guokai Pan
- Hanqing Zhang
- Heran Deng
- Jianglong Zhong
- Jiannan Wu
- Jing Tian
- Jinsong Li
- Lile He
- Liping Xiao
- Lizao Zhang
- Niu Liu
- Qunxing Li
- Soldano Ferrone
- Song Fan
- Teppei Yamada
- Tian Tian
- Tingting Cai
- Weixiong Chen
- Xiaobin Lv
- Xinhui Wang
- Xinyu Lin
- Xinyuan Lei
- Yanliang Zhu
- Yu Peng
- Zezhen Fang
- Zhangsong Wang
- Zhanpeng Ou
- Zhaohui Yang
- Zhiming Tu
Organizations
- Fukuoka University
- Guangzhou Science, Technology and Innovation Commission
- Harvard Medical School
- Nanchang University
- Nanjing Medical University
- National Institutes of Health
- National Natural Science Foundation of China
- Southeast University
- Sun Yat-sen University
- United States Department of Defense